CGON
CG Oncology·NASDAQ
--
--(--)
--
--(--)
CGON fundamentals
CG Oncology (CGON) released its earnings on Nov 14, 2025: revenue was 1.67M (YoY +3774.42%), beat estimates; EPS was -0.57 (YoY -90.00%), missed estimates.
Revenue / YoY
1.67M
+3774.42%
EPS / YoY
-0.57
-90.00%
Report date
Nov 14, 2025
Earnings
EPS
Revenue
Revenue & Expenses
CGON has released its 2025 Q4 earnings report, with revenue of 2.32M, reflecting a YoY change of 409.21%, and net profit of -41.31M, showing a YoY change of -29.91%. The Sankey diagram below clearly presents CGON's revenue sources and cost distribution.
Key Indicators
CG Oncology (CGON) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
CG Oncology (CGON)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
CG Oncology (CGON)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
CG Oncology (CGON)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does CG Oncology (CGON) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track CG Oncology (CGON) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did CG Oncology's management provide for the next earnings period?What is the revenue and EPS growth rate for CG Oncology year over year?What is CG Oncology's latest dividend and current dividend yield?What is the market's earnings forecast for CG Oncology next quarter?What is CG Oncology's gross profit margin?What were the key takeaways from CG Oncology's earnings call?What factors drove the changes in CG Oncology's revenue and profit?Did CG Oncology beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
